Decreased D6D suppresses tumor angiogenesis and inflammation. by Chengwei He (125487)

Decrease in intracellular lipid accumulation in 3T3-L1 cells by baicalein. by Yukari Nakao (3138795)

Terpenoids decrease single-channel activity of L-AChRs elicited by ACh. by Guillermina Hernando (553795)

Decrease in cell viability by siRNA and miRNA dependent induction of DTA. by Liraz Harel (675561)

“…<p>U251 cells were transfected with the indicated construct (50 ng) with (A) or without (B) siRNAs (10pmol). …”

The GluN2B-C456Y mutation decreases recombinant NMDAR currents and alters receptor properties. by Wangyong Shin (6793040)

“…<p>(A) The GluN2B-C456Y mutation strongly decreases diheteromeric GluN1/GluN2B NMDAR currents in <i>Xenopus</i> oocytes. …”

Competitive binding experiment. by Deepu Dowarha (5673440)

Effects of bFGF on decrease of HG-induced accumulation of intracellular ROS levels. by Yuan Hu Xuan (632639)

Conditioning with glucose and sodium ions decreases chemotaxis to sodium ions and glucose, respectively. by Masahiro Tomioka (430683)

Effects of SUN N8075 on the decreased motor neurons and VGF immunoreactivity of the spinal cords of SOD1G93A mice and sporadic ALS patients. by Masamitsu Shimazawa (59118)

Frequency of septicemic plague in the absence of primary pneumonia increases with decreasing dosing volume. by Rachel M. Olson (6729983)

Ce6 decreases the amount of TMV PQS5 upon photo-irradiation. by Congbao Xie (17599247)

Thimerosal decreases the expression of survivin via the PI3K/Akt pathway. by Wen-Xue Li (189757)

Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%. by Joseph Kamgno (81039)

“…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”

Stx16-depleted MDCK monolayer show decreased transepithelial resistance (TER). by Jae-Joon Jung (139625)

TL decreases cell viability in malignant cells dependent of p53 status. by Ajay Kumar (192967)

VASH1 controls SOD2 level and decreases ROS level in HUVECs. by Hiroki Miyashita (131087)

Deletion of STX1B decreases frequency of mEPSCs and mIPSCs. by Tatsuya Mishima (529071)

miR-181b overexpression decreases cell mitochondrial membrane potential. by Samira Ghorbani (3843895)

ku0063794 but not rapamycin decreased the TRPC6 mRNA levels in podocytes. by Fangrui Ding (659863)

“…<p>(A) ku0063794 (2 µmol/l) or rapamycin (50 nmol/l) was applied to evaluate the effects of mTORC1 and mTORC2 on TRPC6 in podocytes. …”

Expression of MHC I is decreased by P2X7R activation. by Alberto Baroja-Mazo (441935)